ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 120 filers reported holding ENZO BIOCHEM INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $389,137 | -9.3% | 356,904 | +5.6% | 0.00% | – |
Q1 2024 | $429,203 | -8.6% | 337,856 | 0.0% | 0.00% | – |
Q4 2023 | $469,746 | -0.7% | 337,856 | 0.0% | 0.00% | – |
Q3 2023 | $473,139 | -23.8% | 337,856 | +0.1% | 0.00% | – |
Q2 2023 | $621,138 | -28.0% | 337,575 | -4.9% | 0.00% | – |
Q1 2023 | $862,752 | +171081.0% | 355,042 | +0.6% | 0.00% | – |
Q4 2022 | $504 | -99.9% | 352,848 | -1.3% | 0.00% | – |
Q3 2022 | $797,000 | +8.0% | 357,544 | +0.3% | 0.00% | – |
Q2 2022 | $738,000 | -27.2% | 356,567 | +1.9% | 0.00% | – |
Q1 2022 | $1,014,000 | -8.8% | 349,821 | +1.0% | 0.00% | – |
Q4 2021 | $1,112,000 | -9.3% | 346,485 | 0.0% | 0.00% | – |
Q3 2021 | $1,226,000 | +10.7% | 346,485 | -0.8% | 0.00% | – |
Q2 2021 | $1,107,000 | -51.2% | 349,221 | -47.1% | 0.00% | – |
Q1 2021 | $2,270,000 | +50.4% | 660,025 | +10.2% | 0.00% | – |
Q4 2020 | $1,509,000 | +21.8% | 599,196 | +2.0% | 0.00% | – |
Q3 2020 | $1,239,000 | -3.8% | 587,482 | +2.2% | 0.00% | – |
Q2 2020 | $1,288,000 | -9.0% | 575,005 | +2.7% | 0.00% | – |
Q1 2020 | $1,416,000 | -47.6% | 559,743 | -45.5% | 0.00% | – |
Q4 2019 | $2,702,000 | +46.9% | 1,027,584 | +101.1% | 0.00% | – |
Q3 2019 | $1,839,000 | +13.2% | 510,865 | +5.9% | 0.00% | – |
Q2 2019 | $1,624,000 | +39.9% | 482,181 | +13.4% | 0.00% | – |
Q1 2019 | $1,161,000 | -49.2% | 425,306 | -48.3% | 0.00% | – |
Q4 2018 | $2,284,000 | +17.3% | 822,276 | +73.9% | 0.00% | -100.0% |
Q3 2018 | $1,947,000 | -17.5% | 472,819 | +3.9% | 0.00% | 0.0% |
Q2 2018 | $2,361,000 | +7.5% | 455,183 | +13.5% | 0.00% | 0.0% |
Q1 2018 | $2,196,000 | -19.7% | 400,938 | +19.4% | 0.00% | 0.0% |
Q4 2017 | $2,736,000 | -21.3% | 335,820 | +1.1% | 0.00% | 0.0% |
Q3 2017 | $3,477,000 | -5.5% | 332,135 | -0.4% | 0.00% | 0.0% |
Q2 2017 | $3,678,000 | +51.0% | 333,302 | +14.5% | 0.00% | 0.0% |
Q1 2017 | $2,436,000 | +31.0% | 291,119 | +8.6% | 0.00% | 0.0% |
Q4 2016 | $1,860,000 | +40.0% | 268,083 | +2.7% | 0.00% | 0.0% |
Q3 2016 | $1,329,000 | -23.2% | 261,118 | -10.0% | 0.00% | 0.0% |
Q2 2016 | $1,730,000 | +110.5% | 289,986 | +60.4% | 0.00% | – |
Q1 2016 | $822,000 | +4.2% | 180,845 | +3.0% | 0.00% | – |
Q4 2015 | $789,000 | +41.9% | 175,536 | 0.0% | 0.00% | – |
Q3 2015 | $556,000 | +16.3% | 175,536 | +11.2% | 0.00% | – |
Q2 2015 | $478,000 | -13.1% | 157,821 | -15.4% | 0.00% | – |
Q1 2015 | $550,000 | -30.8% | 186,603 | +4.0% | 0.00% | – |
Q4 2014 | $795,000 | -12.0% | 179,353 | +2.2% | 0.00% | -100.0% |
Q3 2014 | $903,000 | -1.0% | 175,563 | +1.1% | 0.00% | 0.0% |
Q2 2014 | $912,000 | +47.1% | 173,734 | +16.4% | 0.00% | – |
Q1 2014 | $620,000 | +146.0% | 149,250 | +72.3% | 0.00% | – |
Q4 2013 | $252,000 | +15.6% | 86,628 | 0.0% | 0.00% | – |
Q3 2013 | $218,000 | +21.1% | 86,628 | 0.0% | 0.00% | – |
Q2 2013 | $180,000 | – | 86,628 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARBERT FUND ADVISORS, INC. | 5,620,681 | $20,234,000 | 30.10% |
Evermore Global Advisors, LLC | 4,007,851 | $14,428,000 | 3.48% |
Fondren Management LP | 355,000 | $1,278,000 | 1.06% |
CORRADO ADVISORS, LLC | 196,309 | $707,000 | 0.64% |
MARATHON CAPITAL MANAGEMENT | 193,580 | $697,000 | 0.28% |
KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $344,000 | 0.23% |
EAM Investors, LLC | 203,962 | $734,000 | 0.19% |
Ariel Investments | 1,026,313 | $3,695,000 | 0.05% |
HighVista Strategies LLC | 19,500 | $70,000 | 0.05% |
Paradigm Financial Partners, LLC | 17,175 | $60,000 | 0.03% |